Stay updated on Efficacy and Safety of Cenobamate Adjunctive Therapy in POS Clinical Trial
Sign up to get notified when there's something new on the Efficacy and Safety of Cenobamate Adjunctive Therapy in POS Clinical Trial page.

Latest updates to the Efficacy and Safety of Cenobamate Adjunctive Therapy in POS Clinical Trial page
- Check2 days agoChange DetectedThe study status was updated to Completed and the enrollment is listed as 519. The record now includes recent update dates and a new revision note (Revision: v3.5.5), reflecting the latest changes to the study entry.SummaryDifference1.0%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedA new revision tag (v3.5.4) replaces the previous v3.5.3 on the page, indicating a minor update to the page metadata rather than content.SummaryDifference0.1%

- Check45 days agoChange DetectedThe page’s revision/version indicator was updated from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check52 days agoChange DetectedRevision updated to v3.5.2, replacing the previous v3.5.0.SummaryDifference0.1%

- Check80 days agoChange DetectedA new revision entry v3.5.0 was added and the previous revision v3.4.3 was removed. This is a version update with no visible changes to study details presented on the page.SummaryDifference0.1%

- Check95 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Efficacy and Safety of Cenobamate Adjunctive Therapy in POS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy and Safety of Cenobamate Adjunctive Therapy in POS Clinical Trial page.